Relationship between allergy and cancer: An overview

International Archives of Allergy and Immunology

Volumn 159, Issue 3, 2012, Pages 216-225

  Rittmeyer, Delia ^a   Lorentz, Axel ^a  

^a UNIVERSITY OF HOHENHEIM   (Germany)

Author keywords

Allergy; Cancer; Immunosurveillance; Inflammation

Indexed keywords

GLUCOCORTICOID;

ALLERGIC DISEASE; ALLERGIC RHINITIS; ASTHMA; ATOPIC DERMATITIS; BRAIN CANCER; COLORECTAL CANCER; EPIDEMIOLOGY; IMMUNOSURVEILLANCE; INFLAMMATION; LUNG CANCER; NEOPLASM; PANCREAS CANCER; PRIORITY JOURNAL; REVIEW; SKIN CANCER;

ASIA; COMORBIDITY; CYTOKINES; DATABASES, BIBLIOGRAPHIC; EPIDEMIOLOGIC STUDIES; EUROPE; HUMANS; HYPERSENSITIVITY; IMMUNOGLOBULIN E; IMMUNOLOGIC SURVEILLANCE; INFLAMMATION; MODELS, STATISTICAL; NEOPLASMS; NORTH AMERICA;

EID: 84862493244     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000338994     Document Type: Review

References (64)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D: Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
2. Gaber E, Wildner M: Sterblichkeit, Todesursachen und regionale Unterschiede. Gesundheitsberichterstattung des Bundes. Berlin, Robert Koch-Institut, 2011.
3. American Cancer Society: Cancer Facts & Figures 2010. Atlanta, American Cancer Society, 2010.
4. Hermann-Kunz E: Allergische Krankheiten in Deutschland. Ergebnisse einer repräsentativen Studie. Gesundheitsbl - Gesundheitsforsch - Gesundheitsschutz 2000; 43:400-406.
5. Masoli M, Fabian D, Holt S, Beasley R: The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 2004; 59: 469-478.
6. Mann C: Observational research methods - research design II: cohort, cross sectional, and case-control studies. Emerg Med J 2003; 20: 54-60.
7. Rothman KJ, Greenland S, Lash TL: Modern Epidemiology, ed 3. Philadelphia, Lippincott Williams & Wilkins, 2008.
8. Szklo M, Nieto FJ: Epidemiology: beyond the basics, ed 2. Sudbury, Jones & Bartlett, 2007.
9. Fisherman EW: Does the allergic diathesis influence malignancy? J Allergy 1960; 31: 74- 78.
10. Mackay WD: The incidence of allergic disorders and cancer. Br J Cancer 1966; 20: 434- 437.
11. Allegra J, Lipton A, Harvey H, Luderer J, Brenner D, Mortel R, Demers L, Gillin M, White D, Trautlein J: Decreased prevalence of immediate hypersensitivity (atopy) in a cancer population. Cancer Res 1976; 36: 3225-3226.
12. Turner MC, Chen Y, Krewski D, Ghadirian P, Thun MJ, Calle EE: Cancer mortality among US men and women with asthma and hay fever. Am J Epidemiol 2005; 162: 212-221.
13. Vena JE, Bona JR, Byers TE: Allergy-related diseases and cancer: An inverse association. Am J Epidemiol 1985; 122: 66-74.
14. Mills PK, Beeson WL, Fraser GE, Phillips RL: Allergy and cancer: organ site-specific results from the Adventist Health Study. Am J Epidemiol 1992; 136: 287-295.
15. Hwang CY, Chen YJ, Lin MW, Chen TJ, Chu SY, Chen CC, Lee DD, Chang YT, Wang WJ, Liu HN: Cancer risk in patients with allergic rhinitis, asthma and atopic dermatitis: A nationwide cohort study in Taiwan. Int J Cancer 2012; 130: 1160-1167.
16. McWhorter WP: Allergy and risk of cancer: A prospective study using NHANESI followup data. Cancer 1988; 62: 451-455.
17. Vesterinen E, Pukkala E, Timonen T, Aromaa A: Cancer incidence among 78,000 asthmatic patients. Int J Epidemiol 1993; 22: 976-982.
18. González-Pérez A, Fernández-Vidaurre C, Rueda A, Rivero E, García Rodríguez LA: Cancer incidence in a general population of asthma patients. Pharmacoepidemiol Drug Saf 2006; 15: 131-138.
19. Olesen AB, Engholm G, Storm HH, Thestrup- Pedersen K: The risk of cancer among patients previously hospitalized for atopic dermatitis. J Invest Dermatol 2005; 125: 445- 449.
20. Hagströmer L, Ye W, Nyrén O, Emtestam L: Incidence of cancer among patients with atopic dermatitis. Arch Dermatol 2005; 141: 1123-1127.
21. Arana A, Wentworth CE, Fernández-Vidaurre C, Schlienger RG, Conde E, Arellano FM: Incidence of cancer in the general population and in patients with or without atopic dermatitis in the UK. Br J Dermatol 2010; 163: 1036-1043.
22. Shapiro S, Heinonen OP, Siskind V: Cancer and allergy. Cancer 1971; 28: 396-400.
23. Eriksson NE, Mikoczy Z, Hagmar L: Cancer incidence in 13,811 patients skin tested for allergy. J Invest Allergol Clin Immunol 2005; 15: 161-166.
24. Lindelöf B, Granath F, Tengvall-Linder M, Ekbom A: Allergy and cancer. Allergy 2005; 60: 1116-1120.
25. Pompei R, Lampis G, Ingianni A, Nonnis D, Ionta MT, Massidda B: Allergy and tumour outcome after primary cancer therapy. Int Arch Allergy Immunol 2004; 133: 174-178.
26. Holly EA, Eberle CA, Bracci PM: Prior history of allergies and pancreatic cancer in the San Francisco Bay area. Am J Epidemiol 2003; 158: 432-441.
27. Eppel A, Cotterchio M, Gallinger S: Allergies are associated with reduced pancreas cancer risk: A population-based case-control study in Ontario, Canada. Int J Cancer 2007; 121: 2241-2245.
28. Olson SH, Orlow I, Simon J, Tommasi D, Roy P, Bayuga S, Ludwig E, Zauber AG, Kurtz RC: Allergies, variants in IL-4 and IL-4R - genes, and risk of pancreatic cancer. Cancer Detect Prev 2007; 31: 345-351.
29. Olson SH, Chou JF, Ludwig E, O'Reilly E, Allen PJ, Jarnagin WR, Bayuga S, Simon J, Gonen M, Reisacher WR, Kurtz RC: Allergies, obesity, other risk factors and survival from pancreatic cancer. Int J Cancer 2010; 127: 2412-2419.
30. Santillan AA, Camargo CA Jr, Colditz GA: A meta-analysis of asthma and risk of lung cancer (United States). Cancer Causes Control 2003; 14: 327-334.
31. Negri E, Bosetti C, La Vecchia C, Levi F, Tomei F, Franceschi S: Allergy and other selected diseases and risk of colorectal cancer. Eur J Cancer 1999; 35: 1838-1841.
32. Bosetti C, Talamini R, Franceschi S, Negri E, Giacosa A, La Vecchia C: Allergy and the risk of selected digestive and laryngeal neoplasms. Eur J Cancer Prev 2004; 13: 173-176.
33. Prizment AE, Folsom AR, Cerhan JR, Flood A, Ross JA, Anderson KE: History of allergy and reduced incidence of colorectal cancer, Iowa Women's Health Study. Cancer Epidemiol Biomarkers Prev 2007; 16: 2357-2362.
34. Talbot-Smith A, Fritschi L, Divitini ML, Mallon DFJ, Knuiman MW: Allergy, atopy, and cancer: A prospective study of the 1981 Busselton cohort. Am J Epidemiol 2003; 157: 606-612
35. Brenner AV, Linet MS, Fine HA, Shapiro WR, Selker RG, Black PM, Inskip PD: History of allergies and autoimmune diseases and risk of brain tumors in adults. Int J Cancer 2002; 99: 252-259
36. Schoemaker MJ, Swerdlow AJ, Hepworth SJ, McKinney PA, Van Tongeren M, Muir KR: History of allergies and risk of glioma in adults. Int J Cancer 2006; 119: 2165-2172
37. Wigertz A, Lönn S, Schwartzbaum J, Hall P, Auvinen A, Christensen HC, Johansen C, Klæboe L, Salminen T, Schoemaker MJ, Swerdlow AJ, Tynes T, Feychting M: Allergic conditions and brain tumor risk. Am J Epidemiol 2007; 166: 941-950
38. Wiemels JL, Wilson D, Patil C, Patoka J, Mc- Coy L, Rice T, Schwartzbaum J, Heimberger A, Sampson JH, Chang S, Prados M, Wiencke JK, Wrensch M: IgE, allergy, and risk of glioma: Update from the San Francisco Bay Area Adult Glioma Study in the temozolomide era. Int J Cancer 2009; 125: 680-687
39. Wiemels JL, Wrensch M, Sison JD, Zhou M, Bondy M, Calvocoressi L, Black PM, Yu H, Schildkraut JM, Claus EB: Reduced allergy and immunoglobulin E among adults with intracranial meningioma compared to controls. Int J Cancer 2011; 129: 1932-1939
40. Wang H, Rothenbacher D, Löw M, Stegmaier C, Brenner H, Diepgen TL: Atopic diseases, immunoglobulin E and risk of cancer of the prostate, breast, lung and colorectum. Int J Cancer 2006; 119: 695-701
41. Wang H, Diepgen TL: Is atopy a protective or a risk factor for cancer? A review of epidemiological studies. Allergy 2005; 60: 1098- 1111
42. Turner MC, Chen Y, Krewski D, Ghadirian P: An overview of the association between allergy and cancer. Int J Cancer 2006; 118: 3124-3132
43. Severi G, Baglietto L, Muller DC, English DR, Jenkins MA, Abramson MJ, Douglass JA, Hopper JL, Giles GG: Asthma, asthma medications, and prostate cancer risk. Cancer Epidemiol Biomarkers Prev 2010; 19: 2318-2324
44. Scheurer ME, Amirian ES, Davlin SL, Rice T, Wrensch M, Bondy ML: Effects of antihistamine and anti-inflammatory medication use on risk of specific glioma histologies. Int J Cancer 2011; 129: 2290-2296
45. Arumugam T, Ramachandran V, Logsdon CD: Effect of cromolyn on S100P interactions with RAGE and pancreatic cancer growth and invasion in mouse models. J Natl Cancer Inst 2006; 98: 1806-1818
46. Mesdaghi M, Vodjgani M, Salehi E, Hadjati J, Sarrafnejad A, Bidad K, Berjisian F: Natural killer cells in allergic rhinitis patients and nonatopic controls. Int Arch Allergy Immunol 2010; 153: 234-238
47. Jakóbisiak M, Lasek W, Golab J: Natural mechanisms protecting against cancer. Immunol Lett 2003; 90: 103-122
48. Morse MA, Lyerly HK, Clay TM, Abdel-Wahab O, Chui SY, Garst J, Gollob J, Grossi PM, Kalady M, Mosca PJ, Onaitis M, Sampson JH, Seigler HF, Toloza EM, Tyler D, Vieweg J, Yang Y: How does the immune system attack cancer? Curr Probl Surg 2004; 41: 15- 132
49. Dunn GP, Old LJ, Schreiber RD: The immunobiology of cancer immunosurveillance and immunoediting. Immunity 2004; 21: 137-148
50. Munitz A, Levi-Schaffer F: Eosinophils: 'new' roles for 'old' cells. Allergy 2004; 59: 268-275
51. Jensen-Jarolim E, Achatz G, Turner MC, Karagiannis S, Legrand F, Capron M, Penichet ML, Rodríguez JA, Siccardi AG, Vangelista L, Riemer AB, Gould H: AllergoOncology: The role of IgE-mediated allergy in cancer. Allergy 2008; 63: 1255-1266
52. Rivoltini L, Viggiano V, Spinazze S, Santoro A, Colombo MP, Takatsu K, Parmiani G: In vitro anti-tumor activity of eosinophils from cancer patients treated with subcutaneous administration of interleukin 2: Role of interleukin 5. Int J Cancer 1993; 54: 8-15
53. Ellyard JI, Simson L, Parish CR: Th2-mediated anti-tumour immunity: friend or foe? Tissue Antigens 2007; 70: 1-11
54. Karagiannis SN, Bracher MG, Beavil RL, Beavil AJ, Hunt J, McCloskey N, Thompson RG, East N, Burke F, Sutton BJ, Dombrowicz D, Balkwill FR, Gould HJ: Role of IgE receptors in IgE antibody-dependent cytotoxicity and phagocytosis of ovarian tumor cells by human monocytic cells. Cancer Immunol Immunother 2008; 57: 247-263
55. Fu SL, Pierre J, Smith-Norowitz TA, Hagler M, Bowne W, Pincus MR, Mueller CM, Zenilman ME, Bluth MH: Immunoglobulin E antibodies from pancreatic cancer patients mediate antibody-dependent cell-mediated cytotoxicity against pancreatic cancer cells. Clin Exp Immunol 2008; 153: 401-409
56. Reali E, Greiner JW, Corti A, Gould HJ, Bottazzoli F, Paganelli G, Schlom J, Siccardi AG: IgEs targeted on tumor cells: Therapeutic activity and potential in the design of tumor vaccines. Cancer Res 2001; 61: 5517-5522
57. Volpert OV, Fong T, Koch AE, Peterson JD, Waltenbaugh C, Tepper RI, Bouck NP: Inhibition of angiogenesis by interleukin 4. J Exp Med 1998; 188: 1039-1046
58. Pinto FCH, Menezes GB, Moura SAL, Cassali GD, Teixeira MM, Cara DC: Induction of apoptosis in tumor cells as a mechanism of tumor growth reduction in allergic mice. Pathol Res Pract 2009; 205: 559-567
59. Coussens LM, Werb Z: Inflammation and cancer. Nature 2002; 420: 860-867
60. Balkwill F, Charles KA, Mantovani A: Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell 2005; 7: 211-217
61. Gandini S, Lowenfels AB, Jaffee EM, Armstrong TD, Maisonneuve P: Allergies and the risk of pancreatic cancer: A meta-analysis with review of epidemiology and biological mechanisms. Cancer Epidemiol Biomarkers Prev. 2005; 14: 1908-1916
62. Salminen S, Bouley C, Boutron-Ruault MC, Cummings JH, Franck A, Gibson GR, Isolauri E, Moreau MC, Roberfroid M, Rowland I: Functional food science and gastrointestinal physiology and function. Br J Nutr 1998; 80: 147-171
63. Pachter JS, De Vries HE, Fabry Z: The bloodbrain barrier and its role in immune privilege in the central nervous system. J Neuropathol Exp Neurol 2003; 62: 593-604
64. Linos E, Raine T, Alonso A, Michaud D: Atopy and risk of brain tumors: A meta-analysis. J Natl Cancer Inst 2007; 99: 1544-1550.